Viswanadhan Krishnan
SEC insider (Form 3/4/5 filer). CIK 0001999913. Chief Strategy and Operations at AGIOS PHARMACEUTICALS, INC. (AGIO) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in CAMBRIDGE, MA.
Companies Viswanadhan Krishnan has filed insider reports for
- AGIOS PHARMACEUTICALS, INC. (AGIO): Officer, Chief Strategy and Operations
- CARGO Therapeutics, Inc. (CRGX): Director
Viswanadhan Krishnan
CIK: 0001999913
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
3K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirectPerformance share units
3K shares- - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect8.1K shares- - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect3K shares at avg. $34.71$103K - Mar 5, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect8.1K shares- - Mar 5, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect3K shares at avg. $27.80$82K - Mar 1, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectStock options (right to buy)
52K shares- - Mar 1, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
14K shares- - Aug 19, 2025CRGX
CARGO Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
3.2K shares- - Aug 19, 2025CRGX
CARGO Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 3,000 | - | - | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise Performance share units | 3,000 | - | - | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 8,100 | - | $0 | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 2,959 | $34.71 | $102,707 | Direct |
| Mar 5, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 8,100 | - | $0 | Direct |
| Mar 5, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 2,959 | $27.80 | $82,260 | Direct |
| Mar 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Stock options (right to buy) | 52,000 | - | - | Direct |
| Mar 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 14,000 | - | - | Direct |
| Aug 19, 2025 |  CRGX CARGO Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 3,173 | - | - | Direct |
| Aug 19, 2025 | CRGX CARGO Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 25,000 | - | - | Direct |
1-10 of 13 transactions